The Journal of Orthopaedic Experience & Innovation is an Open Access journal. The advantage of open access journals is that they are accessible to a global readership audience that does not have to pay a subscription fee for the journal. For most journals, the editing and process costs are offset by an Article Processing Fee paid by the author or the author’s institution. Here at The Journal of Orthopaedic Experience & Innovation we believe authors should have ready access to have their work published and therefore we do not charge for submission, acceptance, or article processing fees.

Instructions for Authors:
1. All articles must be submitted in English
2. The files that we accept at MS Word .docx for documents, Please do not submit any PDFs
3. All images and figures are to be incorporated into the MS Word document. Do not send separate files for these.
4. Legends for all figures and tables are to be under these images and in the MS Word Document
5. Do not number the lines
6. Do not include a cover letter or conflicts of interest information
7. If abbreviations are used, please write out the full name followed by the abbreviation in parentheses the first time it appears in the text.
8. If your article has human subjects and/or an institutional review board (IRB) is needed for another reason, please incorporate the appropriate IRB language into the manuscript. All studies involving human subjects should follow the Helsinki Declaration, which can be found here: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
9. You can submit videos as files or links to YouTube videos (YouTube only) 10. All references must be endnotes and not footnotes

It is important to read The ICMJE Statement: Defining the Role of Authors and Contributors: This can be found here: https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html Please follow the following reference format: Journal reference format: Author. Title. Journal. Year;Volume(Issue):First page-last page
Book reference format: Author. Title. Edition, Volume. City: Publisher; Year.
Web reference format: Author of document or website. Title. Date. Accessed Year Mon Day. URL
Meeting Abstracts/Presentations format: Author. Title. In: Program Booklet, Meeting title; Year Day(s). City, State: Association; Year. Page Numbers.
Example: Plancher KD, Shanmugam JP, Petterson SC. The changing face of orthopaedic education: searching for the new reality after COVID-19. Arthrosc Sports Med Rehabil. 2020;2(4):e295-8.
• Types of Articles
o Research Article
 Research Articles are manuscripts reporting primary research.
 This should be written in the format:
• Abstract with sections:
o Introduction or Background or Objective or Purpose
 We will accept either terminology
o Purpose or Objective or Hypothesis (optional)
 We will accept either terminology
 We will only accept 1 section titled Objective
 We will only accept 1 section titled Purpose
o Methods or Materials and Methods or Materials/Methods
 We will accept either terminology
o Results
o Discussion or Conclusion or Conclusions
 We will accept either terminology
 Level of Evidence (optional)
• Introduction
• Methods or Materials and Methods or Methodology
o We will accept either terminology
• Results
• Discussion
• Conclusion or Conclusions (optional)
 We will accept either terminology
• References
 In the discussion, feel free to put your individual spin and style on it. It is very important the readership gets a true idea of what you want to prove or disprove in this study.
 Whatever statistical approach you use, please make sure it is clear and understood why you are choosing that approach.
 Observational studies should follow the STROBE guidelines, which can be found here: https://www.equator-network.org/reporting-guidelines/strobe/
 Clinical Trials should follow the CONSORT guidelines, which can be found here: https://www.equator-network.org/reporting-guidelines/consort/. Additionally, all clinical trials must be registered with a public clinical trial registry.
 We will consider other article and abstract structures on a case-by-case basis.
 Abstract Length: 100-500 words
 Manuscript Length (including abstract, excluding tables, figures, legends, and references): 2,000- 5,000 words
o Case Report
 Case reports are a detailed report of the diagnosis and treatment of an individual patient.
 This should be written in the format:
• Either Unstructured Abstract or Abstract with the following format
 Introduction or Background
 We will accept either terminology
 Case Presentation or Clinical Presentation or Case Report or Case
 We will accept either terminology
 Conclusion or Conclusions
 We will accept either terminology
• Introduction or Background
o We will accept either terminology
• Case Report or Case Presentation or Case History
o We will accept either terminology
• Discussion
• Conclusion or Conclusions or Summary (optional)
o We will accept either terminology
• References
 Journal of Orthopaedic Experience & Innovation follows the CARE case report guidelines which can be found here: https://www.equator-network.org/reporting-guidelines/care/
 We will consider other article and abstract structures on a case-by-case basis.
 Abstract Length: 50-300 words
 Manuscript Length (including abstract, excluding tables, figures, legends, and references): 1,000 – 4,000 words
o Methods Article
 Methods articles discuss new surgical techniques or methodology.
 This should be written in the format:
• Unstructured Abstract
• Introduction or Background
o We will accept either terminology
• Main text should consist of sub-sections to best describe the literature being summarized
• Discussion and/or Conclusion or Conclusions or Summary
• We will accept either terminology References
 We will consider other article and abstract structures on a case-by-case basis.
 Abstract Length: 50-300 words
 Manuscript Length (including abstract, excluding tables, figures, legends, and references): 1,000 – 4,000 words
o Review Article
 Review articles are written to summarize the current knowledge about a specific topic.
 This should be written in the format:
• Unstructured Abstract
 Introduction or Background
 We will accept either terminology
• Main text should consist of sub-sections to best describe the literature being summarized
• Discussion and/or Conclusion or Conclusions or Summary
 We will accept either terminology
• References
 In the discussion, feel free to put your individual spin and style on it. It is very important the readership gets a true idea of what you want to prove or disprove in this study.
 Whatever statistical approach you use, please make sure it is clear and understood why you are choosing that approach.
 We will consider other article and abstract structures on a case-by-case basis.  Abstract Length: 30-300 words
 Manuscript Length (including abstract, excluding tables, figures, legends, and references): 1,000 – 5,000 words
o Systematic Reviews
 A systematic review synthesizes all high-quality literature related to a specific research question.
 This should be written in the format:
• Abstract with sections:
o Introduction or Background
 We will accept either terminology
o Methods
o Results
o Discussion or Conclusion or Conclusions
 We will accept either terminology
• Introduction
• Methods or Materials and Methods
o We will accept either terminology
• Results
• Discussion
• Conclusion (optional)
• References
 Systematic reviews and meta-analyses should follow the PRISMA guidelines which can be found here: https://www.prisma-statement.org/prisma-2020
 We will consider other article and abstract structures on a case-by-case basis.  Abstract Length: 250-400 words
 Manuscript Length (including abstract, excluding tables, figures, legends, and references): 2,000-5,500 words
o Meeting Reports/Abstracts
 These are invited abstracts and/or posters from select conferences. Specific instructions will be sent to invited authors and are conference specific.
o Brief Report
 These are invited short announcement of research results.
 This should be written in the format:
 Unstructured Abstract
 Unstructured Format or structured in format to best convey information
 Abstract Length: 10-50 words
 Manuscript Length (including abstract, excluding tables, figures, legends, and references): 1,000-2,000 words

o Editorial
 Of all the forms of articles, this one is the one with the freest format. If this article is written it is either that you were invited to write about your experience, usually multi-year, with something or you want to write about your experience with a new innovation. This is your chance to truly say it how you want to as if someone asked you the question, “Tell me about your experience with this?”
 This should be written in the format:
 Unstructured Abstract
 Unstructured Format or structured in format to best convey information
 Abstract Length: 10-400 words
 Manuscript Length (including abstract, excluding tables, figures, legends, and references): 500-8,000 words
o Product Review
 Reviews of new technology and products available for use in orthopaedic surgery.
 This should be written in the format:
 Unstructured Abstract
 Unstructured Format or structured in format to best convey information
 Abstract Length: 10-400 words
 Manuscript Length (including abstract, excluding tables, figures, legends, and references): 500-8,000 words
o The Journal of Orthopaedic Experience & Innovation no longer accepts studies involving animals.

Instructions for Authors

The Journal of Orthopaedic Experience & Innovation would not live up to its name if we did not respect the experience of the authors and had some innovative ways to present articles. First let’s get a couple of housekeeping issues out of the way and then discuss the various types of articles and suggested formatting. • All submissions are electronic through our platform. • Go to joei.pub • Click on the navigation tab “For Authors” • You will see a large blue button “Submit a Manuscript”

• Click on this button • If this is your first time that you are submitting a manuscript, we ask that you create an account. You will see the following screen. Click on the X in the top right.

• You will now see the following screen. If this is not the first time you submitted a manuscript, then you already have a login with your email and password that you created. If this is your first time on the platform, create an account by clicking on the button “I need to sign up.” • If you are signing up, after you click the button you will be directed to the following page.

• Make sure you fill out the required fields. • Once you do this and sign in you will be directed to the manuscript submission page:

• The steps are fairly intuitive. • IMPORTANT NOTE: You can either embed images within your manuscript or add them in the supporting files section. WE PREFER YOU ADD THEM IN THE SUPPORTING FILES SECTION. They, of course, will be labeled the same way in the manuscript and the filename. Any media file can be uploaded from images to video files. • In the end, you will submit the manuscript and the rest of the process, including all communications will be done electronically with notifications to your email with direct links to the platform to handle any editorial requests.

In the end, you will submit the manuscript and the rest of the process, including all communications will be done electronically with notifications to your email with direct links to the platform to handle any editorial requests. o Protection of Human Subjects  All studies involving human subjects should have a statement if the study was approved by an institutional review board (IRB). If the study was exempt from IRB approval, then a statement explaining why the study is IRB exempt should be included. Additionally, all studies should follow the Helsinki Declaration, which can be found here: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. An informed consent statement is required for studies involving experimentation on human subjects. IRB approval letters and informed consent documentation should be available upon request. o Protection of Animal Rights  The Journal of Orthopaedic Experience & Innovation no longer publishes studies involving animal subjects. o Funding  All studies must include a statement of funding, if applicable. o Copyright  Copyright on any article in the Journal of Orthopaedic Experience & Innovation is retained by the author(s). o Licensing  Upon acceptance, authors grant the Journal of Orthopaedic Experience & Innovation a Creative Commons BY-NC-ND. More information and the formal terms of this license can be found here : https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode o Assurance of Ownership  In line with ethics of publishing, authors must attest to the fact that they originated and completed the work free of any other copyrights, trademarks, or patents. Additionally, there is no aspect of the work that was used from a previous source without that source’s permission (in other words- no plagiarism). The authors indemnify The Journal of Orthopaedic Experience & Innovation in the event that any manuscript has violations in this area. o Verification  Submission to the Journal of Orthopaedic Experience & Innovation has an implied warranty that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis. Additionally, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the Journal of Orthopaedic Experience & Innovation. o Peer Review Process  The Journal of Orthopaedic Experience & Innovation follows the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (https://www.icmje.org/icmje-recommendations.pdf) and the Principles of Transparency and the Best Practice in Scholarly Publishing (https://oaspa.org/information-resources/principles-of-transparency-and-best-practice-in-scholarly-publishing/).  All manuscripts undergo a double-blind peer-review process. All manuscripts are reviewed by a minimum of 2 reviewers independently. Reviewers and editors are asked to excuse themselves from reviewing manuscripts that they have a conflict of interest, and another reviewer/editor is assigned in their place. After receiving the reviews, the editor(s)-in-chief has full authority to accept, reject, or ask for revisions of all submitted manuscripts. The corresponding author is provided with feedback from the reviewers. If a revised version of a manuscript is submitted, the editor(s)-in-chief will decide if the manuscript requires additional reviews or make a final decision about publication of the manuscript. o Publishing Schedule  The Journal of Orthopaedic Experience & Innovation strives to keep a continuous publication schedule so that articles are published online as soon as they are ready. This results in Journal of Orthopaedic Experience & Innovation publishing on average 4-8 articles per month. Upon publication, all articles are additionally added to the yearly issue of the Journal of Orthopaedic Experience & Innovation. o Editorial Policies  The Journal of Orthopaedic Experience & Innovation follows the COPE Code of Conduct and Best Practice Guidelines for Journal Editors (https://publicationethics.org/files/Code_of_conduct_for_journal_editors_Mar11.pdf). o Ethics  The Journal of Orthopaedic Experience & Innovation follows the COPE for ethics  authorship and contributorship: https://publicationethics.org/authorship  complaints and appeals: https://publicationethics.org/appeals  allegations of research misconduct: https://publicationethics.org/misconduct  conflicts of interest: https://publicationethics.org/competinginterests  On acceptance all authors are required to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.  data sharing and reproducibility: https://publicationethics.org/data  ethical oversight: https://publicationethics.org/oversight  intellectual property: https://publicationethics.org/intellectualproperty  post-publication discussions: https://publicationethics.org/postpublication  corrections and retractions: https://publicationethics.org/postpublication

All Articles tagged metabolic disease

This website uses cookies